 |
|
Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C
Tom Ryu, Young Chang, Soung Won Jeong, Jeong-Ju Yoo, Sae Hwan Lee, Sang Gyune Kim, Young Seok Kim, Hong Soo Kim, Seung Up Kim, Jae Young Jang
Clin Mol Hepatol. 2025;31(2):548-562. Published online 2025 Jan 9 DOI: https://doi.org/10.3350/cmh.2024.0904
|
|
Citations to this article as recorded by
 Editorial: Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral‐Induced Cure of Hepatitis C Virus Infection—Authors' Reply
Yu‐Ping Chang, Jia‐Horng Kao, Chen‐Hua Liu
Alimentary Pharmacology & Therapeutics.2025; 61(9): 1553. CrossRef
|